Latest News
Investors were expecting a little more from the contract logistics company in the second quarter and in 2026 in general.
Via The Motley Fool · August 5, 2026
Disposition executed under pre-established Rule 10b5-1 trading plan; Kent retains $4.71 million in direct holdings.
Via The Motley Fool · August 5, 2026
The company managed to boost its key second-quarter fundamentals at impressive rates.
Via The Motley Fool · August 5, 2026
Customer platform provider HubSpot (NYSE:HUBS) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 19.8% year on year to $9...
Via StockStory · August 5, 2026
Global tire manufacturer Goodyear (NASDAQ:GT) reported Q2 CY2026 results beating Wall Street’s revenue expectations, but sales fell by 4.8% year on year to $...
Via StockStory · August 5, 2026
Data collaboration platform LiveRamp (NYSE:RAMP) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 9.8% year on year to $214 million. Its no...
Via StockStory · August 5, 2026
Iren peaked in Q3 2025 before sliding back, while AeroVironment's revenue more than tripled over the same period.
Via The Motley Fool · August 5, 2026
Oil and gas producer APA Corporation (NASDAQ:APA) missed Wall Street’s revenue expectations in Q2 CY2026 as sales rose 2.8% year on year to $2.37 billion. It...
Via StockStory · August 5, 2026
Alto Ingredients (NASDAQ:ALTO) reported a fourth consecutive quarter of positive gross profit, operating income, net income and adjusted EBITDA in the second quarter of 2026, citing stronger ethanol market conditions, improved essential ingredient pricing and contributions from federal 45Z tax credi
Via MarketBeat · August 5, 2026
AppLovin (NASDAQ:APP) reported second-quarter revenue of $1.92 billion, up 53% from a year earlier and 4% sequentially, while adjusted EBITDA rose 58% year-over-year to $1.61 billion. The company said both figures came in below its own guidance expectations, attributing the shortfall primarily to a
Via MarketBeat · August 5, 2026
Arcutis Biotherapeutics (NASDAQ:ARQT) reported second-quarter 2026 net product revenue of $129.9 million, up 59% from the prior-year period and 23% sequentially, as demand for its ZORYVE topical treatments continued to rise across approved dermatology indications.
The company generated net income o
Via MarketBeat · August 5, 2026
Amtech Systems (NASDAQ:ASYS) reported fiscal 2026 third-quarter revenue of $22.4 million, up 14% from the prior-year period and at the top end of its guidance range, as demand for artificial intelligence-related equipment supported growth in its Thermal Processing Solutions business.
Chairman and C
Via MarketBeat · August 5, 2026
Barrett Business Services (NASDAQ:BBSI) reported second-quarter growth in gross billings and worksite employees, though management said persistent economic uncertainty continued to weigh on hiring among existing clients.
Gross billings increased 2.6% year over year to $2.29 billion for the quarter
Via MarketBeat · August 5, 2026
ADMA Biologics (NASDAQ:ADMA) reported second-quarter revenue growth of 2% as increased sales of its ASCENIV immune globulin product offset pressure on BIVIGAM in the standard immunoglobulin market. The company reiterated its full-year financial outlook and said it remains on track to meet or exceed
Via MarketBeat · August 5, 2026
Airgain (NASDAQ:AIRG) reported second-quarter revenue of $13.7 million, up 19% sequentially and 0.7% from a year earlier, as growth in enterprise, automotive and consumer markets helped the wireless connectivity provider post positive adjusted EBITDA.
President and CEO Jacob Suen said the company e
Via MarketBeat · August 5, 2026
Akebia Therapeutics (NASDAQ:AKBA) reported second-quarter revenue growth for its Vafseo anemia treatment while highlighting an interim clinical result from the VOICE study and progress across its kidney disease pipeline.
Vafseo net product revenue reached $21.3 million in the second quarter of 2026
Via MarketBeat · August 5, 2026
AbCellera Biologics (NASDAQ:ABCL) said it expects to report top-line data “very soon” from its Phase I study of ABCL635, an antibody being evaluated for moderate-to-severe vasomotor symptoms, or hot flashes, associated with menopause.
President and Chief Executive Officer Dr. Carl Hansen said enrol
Via MarketBeat · August 5, 2026
American Coastal Insurance (NASDAQ:ACIC) reported second-quarter net income of $21.9 million as the Florida commercial residential property insurer navigated lower pricing and catastrophe losses while maintaining what management described as disciplined underwriting.
President and CEO Bennett Bradf
Via MarketBeat · August 5, 2026
On Aug. 5, 2026, the ride-hailing giant's profit outlook disappointed investors even as gross bookings surged 24% and revenue hit $14.2 billion.
Via The Motley Fool · August 5, 2026
Business management solutions provider Barrett Business Services (NASDAQ:BBSI) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 3.8% year o...
Via StockStory · August 5, 2026
Latin American e-commerce and fintech company MercadoLibre (NASDAQ:MELI) announced better-than-expected revenue in Q2 CY2026, with sales up 49.8% year on yea...
Via StockStory · August 5, 2026
Quantum computing company IonQ (NYSE:IONQ) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 287% year on year to $80.05 m...
Via StockStory · August 5, 2026
Industrial components supplier NN (NASDAQ:NNBR) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 19.3% year on year to $1...
Via StockStory · August 5, 2026
Digital advertising platform Magnite (NASDAQ:MGNI) missed Wall Street’s revenue expectations in Q2 CY2026, but sales rose 11.2% year on year to $192.8 millio...
Via StockStory · August 5, 2026
Electricity storage and software provider Fluence (NASDAQ:FLNC) missed Wall Street’s revenue expectations in Q2 CY2026, but sales rose 7.9% year on year to $...
Via StockStory · August 5, 2026